Luminescent activity of metallosupramolecular Cd(II) complexes containing dimethylterpyridine ligand

Gorczyński, Adam; Marcinkowski, Damian; Pakulski, Dawid; Kubicki, Maciej; Harrowfield, Jack; Stefankiewicz, Artur R.; Hnatejko, Zbigniew; Patroniak, Violetta

doi:10.1016/j.arabjc.2016.04.006

Cited by 5 publications

(1 citation statement)

References 79 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Closed-shell d 10 metal ions like Cd II and Zn II are known for their labile character in solution 71 , 72 and therefore compounds ( 1 ) and 5 where dissolved in different solvents. For compound ( 5 ), very complex spectra were observed, which precluded any meaningful characterization; most probably the already complex dissymmetric character of the Zn II compound observed in the solid state is further amplified with the additional dissociative equilibria (Fig.…”

Section: Resultsmentioning

confidence: 99%

Unexpected structural complexity of d-block metallosupramolecular architectures within the benzimidazole-phenoxo ligand scaffold for crystal engineering aspects

Marcinkowski,

Kubicki,

Consiglio

et al. 2023

Sci Rep

Self Cite

View full text Add to dashboard Cite

Design of metallosupramolecular materials encompassing more than one kind of supramolecular interaction can become deceptive, but it is necessary to better understand the concept of the controlled formation of supramolecular systems. Herein, we show the structural diversity of the bis-compartmental phenoxo-benzimidazole ligand H3L1 upon self-assembly with variety of d-block metal ions, accounting for factors such as: counterions, pH, solvent and reaction conditions. Solid-state and solution studies show that the parent ligand can accommodate different forms, related to (de)protonation and proton-transfer, resulting in the formation of mono-, bi- or tetrametallic architectures, which was also confirmed with control studies on the new mono-compartmental phenoxo-benzimidazole H2L2 ligand analogue. For the chosen architectures, structural variables such as porous character, magnetic behaviour or luminescence studies were studied to demonstrate how the form of H3L1 ligand affects the final form of the supramolecular architecture and observed properties. Such complex structural variations within the benzimidazole-phenoxo-type ligand have been demonstrated for the first time and this proof-of-concept can be used to integrate these principles in more sophisticated architectures in the future, combining both the benzimidazole and phenoxide subunits. Ultimately, those principles could be utilized for targeted manipulation of properties through molecular tectonics and crystal engineering aspects.

show abstract

Section: Resultsmentioning

confidence: 99%